SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-007111
Filing Date
2018-06-01
Accepted
2018-06-01 09:00:14
Documents
4
Period of Report
2018-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k052918_immudyneinc.htm 8-K 33370
2 FORM OF MEMBERSHIP INTEREST PURCHASE AGREEMENT f8k052918ex10-1_immudyneinc.htm EX-10.1 53891
3 FORM OF LINE OF CREDIT f8k052918ex10-2_immudyneinc.htm EX-10.2 24457
4 AMENDED OPERATING AGREEMENT f8k052918ex10-3_immudyneinc.htm EX-10.3 105053
  Complete submission text file 0001213900-18-007111.txt   218007
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18873516
SIC: 2833 Medicinal Chemicals & Botanical Products